99 related articles for article (PubMed ID: 2476523)
1. Susceptibilities of Mycobacterium leprae and M. avium complex to the H2O2-Fe-mediated halogenation system supplemented with antimicrobial agents.
Tomioka H; Yamada Y; Saito H; Jidoi J
Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):628-32. PubMed ID: 2476523
[TBL] [Abstract][Full Text] [Related]
2. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Matsuoka M; Kashiwabara Y; Namisato M
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
[TBL] [Abstract][Full Text] [Related]
3. A rapid method for viability and drug sensitivity of Mycobacterium leprae cultured in macrophages and using fluorescein diacetate.
Bhagria A; Mahadevan PR
Indian J Lepr; 1987; 59(1):9-19. PubMed ID: 2440960
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid oxidation and the beta-oxidation complex in Mycobacterium leprae and two axenically cultivable mycobacteria that are pathogens.
Wheeler PR; Bulmer K; Ratledge C
J Gen Microbiol; 1991 Apr; 137(4):885-93. PubMed ID: 1856682
[TBL] [Abstract][Full Text] [Related]
5. Interaction of antimycobacterial drugs with the anti-Mycobacterium avium complex effects of antimicrobial effectors, reactive oxygen intermediates, reactive nitrogen intermediates, and free fatty acids produced by macrophages.
Sano K; Tomioka H; Sato K; Sano C; Kawauchi H; Cai S; Shimizu T
Antimicrob Agents Chemother; 2004 Jun; 48(6):2132-9. PubMed ID: 15155211
[TBL] [Abstract][Full Text] [Related]
6. Staining tissue-derived Mycobacterium leprae with fluorescein diacetate and ethidium bromide.
Kvach JT; Munguia G; Strand SH
Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):176-82. PubMed ID: 6202650
[TBL] [Abstract][Full Text] [Related]
7. Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae.
Cambau E; Perani E; Guillemin I; Jamet P; Ji B
Lancet; 1997 Jan; 349(9045):103-4. PubMed ID: 8996430
[No Abstract] [Full Text] [Related]
8. Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex.
Rastogi N; Goh KS; Bryskier A
Antimicrob Agents Chemother; 1994 Jun; 38(6):1433-8. PubMed ID: 8092850
[TBL] [Abstract][Full Text] [Related]
9. Assessing the viability of Mycobacterium leprae by the fluorescein diacetate/ethidium bromide staining technique.
Palomino JC; Falconi E; Marin D; Guerra H
Indian J Lepr; 1991; 63(2):203-8. PubMed ID: 1723741
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
Dhople AM; Lamoureux LC; Gardner GD
Indian J Lepr; 1991; 63(2):166-79. PubMed ID: 1664440
[TBL] [Abstract][Full Text] [Related]
11. Effect of chemotherapy on viability of Mycobacterium leprae as determined by ATP content, morphological index and FDA-EB fluorescent staining.
Katoch VM; Katoch K; Ramanathan U; Sharma VD; Shivannavar CT; Datta AK; Bharadwaj VP
Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):615-21. PubMed ID: 2476522
[TBL] [Abstract][Full Text] [Related]
12. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
Walker LL; Van Landingham RM; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
[TBL] [Abstract][Full Text] [Related]
13. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
[TBL] [Abstract][Full Text] [Related]
14. A fluorescent staining procedure for determining the viability of mycobacterial cells.
Kvach JT; Veras JR
Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):183-92. PubMed ID: 6180992
[TBL] [Abstract][Full Text] [Related]
15. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
[TBL] [Abstract][Full Text] [Related]
16. In vitro synergistic activity between ofloxacin and ansamycins against Mycobacterium leprae.
Dhople AM; Ibanez MA; Gardner GD
Arzneimittelforschung; 1993 Mar; 43(3):384-6. PubMed ID: 8387790
[TBL] [Abstract][Full Text] [Related]
17. OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil.
Cunha Mda G; Virmond M; Schettini AP; Cruz RC; Ura S; Ghuidella C; Viana Fdos R; Avelleira JC; Campos AA; Filho B
Lepr Rev; 2012 Sep; 83(3):261-8. PubMed ID: 23356027
[TBL] [Abstract][Full Text] [Related]
18. Activity of ascorbic acid in inhibiting the multiplication of M. leprae in the mouse foot pad.
Hastings RC; Richard V; Christy SA; Morales MJ
Int J Lepr Other Mycobact Dis; 1976; 44(4):427-30. PubMed ID: 798727
[TBL] [Abstract][Full Text] [Related]
19. Clofazimine modulates the expression of lipid metabolism proteins in Mycobacterium leprae-infected macrophages.
Degang Y; Akama T; Hara T; Tanigawa K; Ishido Y; Gidoh M; Makino M; Ishii N; Suzuki K
PLoS Negl Trop Dis; 2012; 6(12):e1936. PubMed ID: 23236531
[TBL] [Abstract][Full Text] [Related]
20. [Basic evaluation for new antimicrobial susceptibility testing of Mycobacterium leprae by bioluminescence assay (ATP method)].
Yamazaki T; Gidoh M; Matsuoka M
Nihon Hansenbyo Gakkai Zasshi; 2006 Sep; 75(3):227-37. PubMed ID: 17037377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
